Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sentinel Node Biopsy in Breast Cancner: Omission of Axillary Clearance After Micrometastasis (SENOMIC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Karolinska University Hospital
Sponsor:
Collaborators:
Karolinska Institutet
Centrallasarettet Västerås
Uppsala University
Information provided by (Responsible Party):
Jana de Boniface, Karolinska University Hospital
ClinicalTrials.gov Identifier:
NCT02049632
First received: January 24, 2014
Last updated: September 1, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)